Published January 1, 2021 | Version v1
Journal article Open

Interrogating Glioma-Associated Microglia and Macrophage Dynamics Under CSF-1R Therapy with Multitracer In Vivo PET/MRI


Glioma-associated microglia and macrophages (GAMMs) are key players in creating an immunosuppressive microenvironment. They can be efficiently targeted by inhibiting the colony-stimulating factor 1 receptor (CSF-1R). We applied noninvasive PET/CT and PET/MRI
using 18F-fluoroethyltyrosine (18F-FET) (amino acid metabolism) and N,N-diethyl-2-[4-(2-18F-fluoroethoxy)phenyl]-5,7-dimethylpyrazolo [1,5-a]pyrimidine-3-acetamide (18F-DPA-714) (translocator protein) to understand the role of GAMMs in glioma initiation, monitor in vivo therapy-induced GAMM depletion, and observe GAMM repopulation after drug withdrawal.

Methods: C57BL/6 mice (n 5 44) orthotopically implanted with syngeneic mouse GL261 glioma cells were treated with different regimens using the CSF-1R inhibitor PLX5622 (6-fluoro-N-((5-fluoro-2-methoxypyridin-3-yl)methyl)-5-((5-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)methyl)pyridin-2-amine) or vehicle, establishing a preconditioning model and a repopulation model, respectively. The mice underwent longitudinal PET/CT and PET/MRI.

The preconditioning model indicated similar tumor growth based on MRI (44.5%6 24.8%), 18F-FET PET (18.3%6 11.3%), and 18F-DPA-714 PET (16% 6 19.04%) volume dynamics in all groups, suggesting that GAMMs are not involved in glioma initiation. The repopulation
model showed significantly reduced 18F-DPA-714 uptake (245.6% 618.4%), significantly reduced GAMM infiltration even after repopulation, and a significantly decreased tumor volume (254.29% 6 8.6%)with repopulation as measured by MRI, supported by a significant reduction in 18F-FET uptake (250.2% 6 5.3%).

Conclusion: 18F-FET and 18F-DPA-714 PET/MRI allow noninvasive assessment of glioma growth under various regimens of CSF-1R therapy. CSF-1R–mediated modulation of GAMMs may be of high interest as therapy or cotherapy against glioma.


Foray et al JNM 2022.pdf

Files (2.7 MB)

Name Size Download all
2.7 MB Preview Download

Additional details


PET3D – PET Imaging in Drug Design and Development 675417
European Commission
Immune-Image – Immune-Image: Specific Imaging of Immune Cell Dynamics Using Novel Tracer Strategies 831514
European Commission
INMIND – Imaging of Neuroinflammation in Neurodegenerative Diseases 278850
European Commission